Should patients with neutropenia be screened for aspergillosis, eg, with periodic galactomannan testing? Is a positive galactomannan test result without abnormal radiologic findings an indication to initiate treatment in a patient with neutropenia?
When to include a fungal infection in the differential diagnosis in an immunosuppressed patient?
When should patients with neutropenia receive antibiotics for infection prevention? Which agents and regimens should be used? Should antibiotics be used in patients with extreme non-chemotherapy-induced neutropenia who are not more prone to infections than the general population?
As far as you are in a position to judge, in what ways was the response to COVID-19 different in South Asian countries compared with the rest of the world?
If you were to name the 3 most important recent advances in infectious diseases in South Asia that are relevant for everyday practice, what would they be?
You have extensive experience in managing COVID-19. If you were to advise colleagues without such experience, what would you tell them to pay special attention to?
Does the clinical presentation of SARS-CoV-2 infection in South Asian populations differ from other countries?
If you were to name the 3 most important advances in infectious diseases in South Asia that are relevant for everyday practice, what would they be?
What is the impact of ongoing climate changes on the spread of infectious diseases? Are these phenomena relevant to countries in temperate climate zones?
What should the COVID-19 pandemic teach us in terms of the risk of future international-scale epidemics? What lessons on public health should we learn from the course of this pandemic?
English
Polski
Español
українська